Skip to main content
. 2020 Mar 31;53(5):555–561. doi: 10.5946/ce.2019.210

Table 3.

Adverse Events Related to Sedation

M + M group (n=35) M + P group (n=34) M + E group (n=36) p-value
Overall cardiovascular adverse events, n (%) 8 (22.9) 5 (14.7) 6 (16.7)
 Tachycardia 6 (17.1) 3 (8.8) 5 (13.9) 0.634
 Bradycardia 0 (0.0) 0 (0.0) 0 (0.0) 1.0
 Transient hypotension 2 (5.7) 2 (5.9) 1 (2.8) 0.740
 Arrhythmia 0 (0.0) 0 (0.0) 0 (0.0) 1.0
Overall respiratory adverse events, n (%) 1 (2.8) 3 (8.8) 4 (11.1) 0.434
Myoclonus, n (%)
 Occurrence 0 (0.0) 0 (0.0) 3 (8.3) 0.105